Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Langerhans Cells

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Langerhans Cells:

Pubmed Logo
Central granular cell odontogenic tumor: a histopathologic and immunohistochemical study.
The central granular cell odontogenic tumor (CGCOT) is a rare lesion that...
18th November, 2009
Department of Dentistry, University of Diamantina, UFVJM, CEP: 39100-000 Ann Diagn Pathol. 2009 Dec;13(6):405-12. Epub 2009 May 21.
DOI Direct Link
Environmental toxins, a potential risk factor for diabetes among Canadian Aboriginals.
Objectives. To review the current literature to determine if there is a...
18th November, 2009
Environmental Stewardship Unit, Assembly of First Nations, Ottawa, ON K1R Int J Circumpolar Health. 2009 Sep;68(4):316-26.
Lack of retinoic acid leads to increased langerin-expressing dendritic cells in gut-associated lymphoid tissues.
BACKGROUND & AIMS:: Retinoic acid (RA) is a crucial factor for maintaining...
17th November, 2009
Mucosal Immunology Section, Laboratory Science Division, International Gastroenterology. 2009 Nov 12.
DOI Direct Link
[Eosinophilic granuloma of the mandible--a case report]
BACKGROUND: Langerhans cell histiocytosis is characterized by a clonal...
17th November, 2009
Klinik fur Mund-, Kiefer-, Gesichtschirurgie, Oralchirurgie, Luzerner Schweiz Monatsschr Zahnmed. 2009;119(9):887-96.
Cauterization of Central Cornea Induces Recruitment of Major Histocompatibility Complex Class II+ Langerhans Cells From Limbal Basal Epithelium.
PURPOSE:: The purpose of this study was to investigate the distribution...
13th November, 2009
From the *Eye Institute, Xiamen University School of Medicine, Xiamen, Cornea. 2009 Nov 11.
DOI Direct Link

View more research publications.

Press Releases About Langerhans Cells:

BioPortfolio Logo
ASH Announces 2009 Merit Award Winners 25th November, 2009 American Society of Hematology
WASHINGTON, Nov. 25 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH) is pleased to recognize the following abstract presenters with the highest scoring abstracts in the categories
Reportlinker Adds Cell/Tissue Culture Supplies - A Global Market Perspective 25th November, 2009 Reportlinker
NEW YORK, Nov. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Cell/Tissue Culture Supplies - A Global Market Perspective http://www
Reportlinker Adds Regenerative Medicine - Global Market Trends 25th November, 2009 Reportlinker
NEW YORK, Nov. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Regenerative Medicine - Global Market Trends http://www.reportlinker.com
Reportlinker Adds Blood Banking and Blood Products - Global Market Perspective 25th November, 2009 Reportlinker
NEW YORK, Nov. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Blood Banking and Blood Products - Global Market Perspective http://www
American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 19th November, 2009 American BioSciences
BLAUVELT, N.Y., Nov. 19 /PRNewswire/ -- Dr. Mate Hidvegi, inventor of Avemar fermented wheat germ extract, responds to a press release issued on November 17 by Biropharma Kft, discrediting the

BioNews Results for Langerhans Cells:

RSS Logo
BioPortfolio Logo
Epidermal Langerhans Cells Rapidly Capture and Present Antigens from C-Type Lectin-Targeting Antibodies Deposited in the Dermis
Journal of Investigative Dermatology:  Nov 5 2009 1:14PM Matching: langerhans cells
Epidermal Langerhans Cells Are Not Required for UV-Induced Immunosuppression
MDLinx:  Oct 22 2009 12:28PM Matching: langerhans cells

Langerhans Cells Patents:

USPTO Logo
US Patent No.Title
7538097 Inhibition of antigen presentation with poorly catabolized polymers
7557190 Optimized proteins that target Ep-CAM
7557200 Superior molecular vaccine based on self-replicating RNA, suicidal DNA or naked DNA vector, that links antigen with polypeptide that promotes antigen presentation
7560118 Attenuated dengue virus comprising mutations in the NS3 gene
7560247 Nucleic acids encoding anti-IL-12 antibodies, and methods of production

View more patents.

Companies working in the area of Langerhans Cells from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

Genetic Immunity, LLC

Genetic Immunity is a biopharmaceutical company focused on therapeutic vaccine development and commercialization. The lead product, DermaVir vaccine patch, is under clinical evaluation in Hungary and...
www.geneticimmunity.com/        View full profile
Thumbshot

BioPortfolio Ltd. offers e-mail and postal lists for Langerhans Cells scientists - we have details of around 597 individuals working on Langerhans Cells .


This page has been viewed 281 times
Recent Search Terms used to find this page: lANGERHANS CELLS AND COMPANY AND PRODUCT | 2008 langerhans | Dermavir uspatents | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Langerhans Cells across BioPortfolio, or for Langerhans Cells Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.